Dolby Laboratories vs InterDigital
DLB and IDCC side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DLB and IDCC compare
InterDigital is the larger company, worth 1.3 times as much as Dolby Laboratories ($7.6B against $6.1B).
On earnings, Dolby Laboratories is cheaper: it trades at 27.5× trailing earnings, against 32.5× for InterDigital.
Dolby Laboratories grew revenue faster over the last twelve months (0.55% versus −12.0% for InterDigital).
InterDigital keeps more of each dollar of sales as profit, with a net margin of 38.5% compared with 16.7% at Dolby Laboratories.
Both pay dividends: Dolby Laboratories yields 2.2% and InterDigital 0.96%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DLB | IDCC |
|---|---|---|
| Size and price | ||
| Market cap | $6.1B | $7.6B |
| Share price | $64.59 | $295.41 |
| Change, 1 year | −1.8% | −20.5% |
| Change, 5 years | −27.9% | 311% |
| Beta (5Y) | 0.75 | 0.90 |
| Employees | 2,051 | 460 |
| StockData Score | ||
| Total score | 18 | 18 |
| Valuation score | 2 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 4 | 6 (better) |
| Health score | 6 | 6 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 27.5× (better) | 32.5× |
| P/S | 4.5× (better) | 9.3× |
| P/B | 2.3× (better) | 6.1× |
| EV/EBITDA | 16.2× | 15.2× (better) |
| P/FCF | 15.4× (better) | 24.7× |
| PEG | 2.09 | 0.57 (better) |
| FCF yield | 6.5% (better) | 4.1% |
| Fair value | $60.87 | $191.90 |
| Margin of safety | −6.1% (better) | −53.9% |
| Growth | ||
| Revenue growth (TTM) | 0.55% (better) | −12.0% |
| Revenue growth, 5Y average | 3.0% | 18.4% (better) |
| Net income growth (TTM) | −14.4% (better) | −36.6% |
| EPS growth (TTM) | −13.6% (better) | −38.7% |
| EPS growth, 5Y average | 3.1% | 52.3% (better) |
| Profitability | ||
| Gross margin | 87.6% | – |
| Operating margin | 17.7% | 45.1% (better) |
| Net margin | 16.7% | 38.5% (better) |
| FCF margin | 29.0% | 37.8% (better) |
| Return on equity | 8.7% | 26.8% (better) |
| Return on invested capital | 10.5% | 83.8% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.25 (better) |
| Net debt / EBITDA | – | −1.82 |
| Interest coverage | – | 9.9× |
| Current ratio | 3.19 (better) | 1.90 |
| Altman Z-score | 8.62 (better) | 7.82 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.2% (better) | 0.96% |
| Payout ratio | 59.4% | 22.9% |
| Years of dividend growth | 4 (better) | 3 |
| Dividend growth, 5Y average | 8.4% | 13.2% (better) |
| Buyback yield | 3.9% (better) | 1.1% |
| Shareholder yield | 6.1% (better) | 2.1% |
| Ownership | ||
| Held by institutions | 66.1% | 106% |
| Held by insiders | 37.9% | 2.1% |
| Insider net buying, 12 months | −$11.4M (better) | −$26.2M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 10.3% | 10.6% |
Go deeper
- DLB stock overview
- DLB income statement
- DLB valuation and score
- IDCC stock overview
- IDCC income statement
- IDCC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.